Craniometrix Analysis
What is Craniometrix?
Craniometrix delivers AI-driven care navigation for dementia patients, integrating MIND at Home clinical models and specialty-trained navigators. The platform supports comprehensive assessments, personalized care planning, and 24/7 caregiver support. It enables providers to meet Medicare's GUIDE requirements and generate new revenue through patient care programs.
Location
New York, United States
Employees
11-50
Founded
2021
Audit Date
2025-07-25
Audit Staleness
6-12 months stale
Audit Type
SOC 2 Type 2
Funding Status
Series A
Infra Provider
AWS
YC Batch
W22
Product Features & Capabilities
- Care navigation services, AI-powered care navigation software, compliance with Medicare's GUIDE Model, collaborative care platform for healthcare professionals.
Who are the founders of Craniometrix
NP
Nikhil Patel
CEO
NP
Neel Patel
CTO
Market Focus
Craniometrix primarily focuses on the healthcare industry, specifically in providing innovative dementia care solutions through the use of AI-powered navigation software to enhance patient outcomes and support healthcare providers.
Investors
- Olive Tree Capital
- J Ventures
- Cathexis Ventures
- Defy Partners Management
- Quiet Capital
- Rebel Fund
Business Model
Revenue from Medicare's GUIDE Model; supports dementia care through insurance reimbursement.
Competitors Overview
Craniometrix operates in the dementia care solutions market, where its main competitors include:
- Fives Lives: Founded in 2019, this London-based company focuses on risk detection and prevention of dementia. It has raised $3.82 million in funding, positioning it as a more established player c
See something that needs updating? Suggest edits to this profile.